Charming Medical (MCTA) stock is soaring 14.75% in intraday trading on Tuesday, following the company's announcement of its Initial Public Offering (IPO) and listing on the Nasdaq exchange. This significant move comes as the medical company takes a major step towards expanding its presence in the public markets.

The company revealed that it is offering 1.6 million shares at a price of $4.00 per share as part of its IPO. This pricing strategy and the number of shares offered suggest a strong interest from investors and a positive outlook for the company's future. The listing on Nasdaq, one of the world's premier stock exchanges, is likely to increase Charming Medical's visibility and accessibility to a broader range of investors.

Investors appear to be reacting positively to this news, driving up the stock price significantly. The IPO and Nasdaq listing are often seen as milestones for growing companies, potentially indicating strong financial health and future growth prospects. As trading continues, market participants will be closely watching Charming Medical's performance in its early days as a publicly traded company on this major exchange.